UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes

The Journal of urology, 2016-04, Vol.195 (4 Pt 1), p.942-948

2016

Volltextzugriff (PDF)

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53

Nature genetics, 2006-10, Vol.38 (10), p.1133-1141

2006

Volltextzugriff (PDF)

In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion

Clinical cancer research, 2006-12, Vol.12 (23), p.7126-7131

2006

Volltextzugriff (PDF)

Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer

Cancer research (Chicago, Ill.), 2011-05, Vol.71 (9), p.3317-3327

2011

Volltextzugriff (PDF)

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human

Nature genetics, 2003-02, Vol.33 (2), p.162-167

2003

Volltextzugriff (PDF)

Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies

Blood, 2006-01, Vol.107 (1), p.250-256

2006

Volltextzugriff (PDF)

Epigenetic Inactivation Implies a Tumor Suppressor Function in Hematologic Malignancies for Polo-Like Kinase 2 but not Polo-Like Kinase 3

Cell cycle (Georgetown, Tex.), 2006-06, Vol.5 (12), p.1262-1264

2006

Volltextzugriff (PDF)

Epigenetic Inactivation Implies Independent Functions for Insulin-like Growth Factor Binding Protein (IGFBP)-Related Protein 1 and the Related IGFBPL1 in Inhibiting Breast Cancer Phenotypes

Clinical cancer research, 2007-07, Vol.13 (14), p.4061-4068

2007

Volltextzugriff (PDF)

Real world experience of molecular landscape of uveal melanomas: Implications for personalized medicine strategies

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e21572-e21572

2024

Volltextzugriff (PDF)

Evaluation of survival outcomes in patients with solid organ cancer with brain metastasis treated with exacta encylopedic tumor analysis based treatments

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.2033-2033

2024

Volltextzugriff (PDF)

Outcomes of personalized therapy guided by Exacta encyclopedic tumor analysis for women with broadly refractory advanced breast cancer

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13124-e13124

2024

Volltextzugriff (PDF)

Comprehensive molecular profiling from liquid and tissue for analysing the somatic mutational landscape in an Indian breast cancer cohort

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13080-e13080

2023

Volltextzugriff (PDF)

Why does cytotoxic chemotherapy cure only some cancers?

Nature clinical practice. Oncology, 2009-01, Vol.6 (1), p.43-52

2009

Volltextzugriff (PDF)

Abstract 2647: Bromodomain-containing protein 7 (BRD7) is a candidate tumor suppressor in breast carcinoma and prognostic biomarker

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2647-2647

2018

Volltextzugriff (PDF)

Bromodomain-containing protein 7 as tumour suppressor and prognostic biomarker in breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e24047-e24047

2018

Volltextzugriff (PDF)

Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response

Nature (London), 2007-08, Vol.448 (7157), p.1063-1067

2007

Volltextzugriff (PDF)

The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma

AIDS (London), 2009-08, Vol.23 (13), p.1701-1706

2009

Volltextzugriff (PDF)

Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic strategy for glioblastoma

Proceedings of the National Academy of Sciences - PNAS, 2022-08, Vol.119 (32)

2022

Volltextzugriff (PDF)

Inhibition of the angiotensin II type 2 receptor AT 2 R is a novel therapeutic strategy for glioblastoma

Proceedings of the National Academy of Sciences - PNAS, 2022-08, Vol.119 (32), p.e2116289119

2022

Volltextzugriff (PDF)

Abstract 3197: Splicing factors and the role of Navitoclax in drug-resistant ovarian cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3197-3197

2017

Volltextzugriff (PDF)

PD20-01 TANEZUMAB REDUCES PAIN IN WOMEN WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

The Journal of urology, 2015-04, Vol.193 (4S)

2015

Volltextzugriff (PDF)

Virtual metastatic breast multidisciplinary meeting: The next step in personalised medicine

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18794-e18794

2018

Volltextzugriff (PDF)

Abstract 3613: Methylated PLK2 predicts response to taxanes

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3613-3613

2012

Volltextzugriff (PDF)

Surgical oncology: why biopsying metastatic breast cancer should be routine

Nature reviews. Clinical oncology, 2010-02, Vol.7 (2), p.72

2010

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(118)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes

Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53

In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion

Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human

Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies

Epigenetic Inactivation Implies a Tumor Suppressor Function in Hematologic Malignancies for Polo-Like Kinase 2 but not Polo-Like Kinase 3

Epigenetic Inactivation Implies Independent Functions for Insulin-like Growth Factor Binding Protein (IGFBP)-Related Protein 1 and the Related IGFBPL1 in Inhibiting Breast Cancer Phenotypes

Real world experience of molecular landscape of uveal melanomas: Implications for personalized medicine strategies

Evaluation of survival outcomes in patients with solid organ cancer with brain metastasis treated with exacta encylopedic tumor analysis based treatments

Outcomes of personalized therapy guided by Exacta encyclopedic tumor analysis for women with broadly refractory advanced breast cancer

Comprehensive molecular profiling from liquid and tissue for analysing the somatic mutational landscape in an Indian breast cancer cohort

Why does cytotoxic chemotherapy cure only some cancers?

Abstract 2647: Bromodomain-containing protein 7 (BRD7) is a candidate tumor suppressor in breast carcinoma and prognostic biomarker

Bromodomain-containing protein 7 as tumour suppressor and prognostic biomarker in breast cancer

Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response

The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma

Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic strategy for glioblastoma

Inhibition of the angiotensin II type 2 receptor AT 2 R is a novel therapeutic strategy for glioblastoma

Abstract 3197: Splicing factors and the role of Navitoclax in drug-resistant ovarian cancer

PD20-01 TANEZUMAB REDUCES PAIN IN WOMEN WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

Virtual metastatic breast multidisciplinary meeting: The next step in personalised medicine

Abstract 3613: Methylated PLK2 predicts response to taxanes

Surgical oncology: why biopsying metastatic breast cancer should be routine

Aktive Filter

Suchergebnisse filtern